Neptune Wellness Solutions Inc (NASDAQ:NEPT) Receives Average Rating of “Hold” from Analysts

Share on StockTwits

Shares of Neptune Wellness Solutions Inc (NASDAQ:NEPT) (TSE:NTB) have received an average rating of “Hold” from the six analysts that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating and three have assigned a buy rating to the company.

NEPT has been the topic of several research analyst reports. Desjardins restated a “buy” rating on shares of Neptune Wellness Solutions in a research note on Wednesday, November 6th. BidaskClub downgraded Neptune Wellness Solutions from a “sell” rating to a “strong sell” rating in a research note on Friday, September 20th. ValuEngine upgraded Neptune Wellness Solutions from a “hold” rating to a “buy” rating in a research note on Thursday, September 19th. TheStreet downgraded Neptune Wellness Solutions from a “c-” rating to a “d+” rating in a research note on Tuesday, October 15th. Finally, Echelon Wealth Partners restated a “buy” rating on shares of Neptune Wellness Solutions in a research note on Wednesday, July 24th.

Shares of NEPT traded down $0.32 during trading hours on Monday, hitting $2.64. The company had a trading volume of 1,585,500 shares, compared to its average volume of 883,303. The company has a market capitalization of $273.65 million, a PE ratio of -18.86 and a beta of 1.86. Neptune Wellness Solutions has a one year low of $2.42 and a one year high of $6.57. The company’s fifty day moving average price is $3.48 and its two-hundred day moving average price is $4.25.

Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last released its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported ($0.06) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.03) by ($0.03). Neptune Wellness Solutions had a negative return on equity of 48.71% and a negative net margin of 187.60%. The company had revenue of $3.26 million during the quarter, compared to the consensus estimate of $4.51 million. Sell-side analysts predict that Neptune Wellness Solutions will post -0.02 earnings per share for the current year.

Hedge funds have recently made changes to their positions in the stock. Morgan Stanley grew its stake in Neptune Wellness Solutions by 9.1% during the 2nd quarter. Morgan Stanley now owns 208,980 shares of the biotechnology company’s stock worth $909,000 after buying an additional 17,361 shares during the last quarter. Jane Street Group LLC grew its stake in Neptune Wellness Solutions by 45.9% during the 2nd quarter. Jane Street Group LLC now owns 22,598 shares of the biotechnology company’s stock valued at $98,000 after purchasing an additional 7,106 shares during the last quarter. Signition LP purchased a new stake in Neptune Wellness Solutions during the 2nd quarter valued at about $87,000. Tower Research Capital LLC TRC grew its stake in Neptune Wellness Solutions by 265.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 9,929 shares of the biotechnology company’s stock valued at $43,000 after purchasing an additional 7,214 shares during the last quarter. Finally, Wells Fargo & Company MN grew its stake in Neptune Wellness Solutions by 19.4% during the 2nd quarter. Wells Fargo & Company MN now owns 15,362 shares of the biotechnology company’s stock valued at $67,000 after purchasing an additional 2,500 shares during the last quarter. Hedge funds and other institutional investors own 11.82% of the company’s stock.

About Neptune Wellness Solutions

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

Recommended Story: How to invest using market indexes

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Ocean Protocol  Trading Up 44.8% Over Last 7 Days
Ocean Protocol Trading Up 44.8% Over Last 7 Days
Deutsche eMark  1-Day Volume Tops $66.00
Deutsche eMark 1-Day Volume Tops $66.00
Paytomat Hits 24-Hour Trading Volume of $74,234.00
Paytomat Hits 24-Hour Trading Volume of $74,234.00
CanYaCoin  24 Hour Volume Tops $3,002.00
CanYaCoin 24 Hour Volume Tops $3,002.00
Analysts Set Encompass Health Corp  Price Target at $71.75
Analysts Set Encompass Health Corp Price Target at $71.75
Companhia Paranaense de Energia  Given Consensus Recommendation of “Hold” by Analysts
Companhia Paranaense de Energia Given Consensus Recommendation of “Hold” by Analysts


 
© 2006-2019 Zolmax.